The results of the Evaluation of LIXisenatide in Acute coronary syndrome (ELIXA) trial, the first cardiovascular outcomes trial for the short-acting GLP-1 RA lixisenatide, were also published recently [52]
doi: 10.1016/S0140-6736(18)32261-X 22 HolmanR
Li P, Varghese JS, Shah MK, et al
Consulte sempre um profissional de sade para orientao personalizada
How It Works Comprehensive Genetic Analysis : PhenoType Testing evaluates a range of genetic factors that impact your metabolism, hormone levels, and overall health
Epithalon is for research purposes only and is not intended for human or animal use, diagnosis, treatment, or consumption